PNC Financial Services Group’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-250
| Closed | -$1.01K | – | 4821 |
|
2024
Q2 | $1.01K | Sell |
250
-117
| -32% | -$472 | ﹤0.01% | 4424 |
|
2024
Q1 | $2.16K | Hold |
367
| – | – | ﹤0.01% | 4178 |
|
2023
Q4 | $1.36K | Hold |
367
| – | – | ﹤0.01% | 4257 |
|
2023
Q3 | $2.03K | Hold |
367
| – | – | ﹤0.01% | 4243 |
|
2023
Q2 | $4K | Hold |
367
| – | – | ﹤0.01% | 4170 |
|
2023
Q1 | $4.58K | Hold |
367
| – | – | ﹤0.01% | 4066 |
|
2022
Q4 | $3.65K | Hold |
367
| – | – | ﹤0.01% | 4097 |
|
2022
Q3 | $4K | Buy |
367
+84
| +30% | +$916 | ﹤0.01% | 4010 |
|
2022
Q2 | $4K | Buy |
283
+83
| +42% | +$1.17K | ﹤0.01% | 4041 |
|
2022
Q1 | $4K | Hold |
200
| – | – | ﹤0.01% | 4047 |
|
2021
Q4 | $5K | Buy |
200
+83
| +71% | +$2.08K | ﹤0.01% | 3968 |
|
2021
Q3 | $2K | Buy |
+117
| New | +$2K | ﹤0.01% | 4096 |
|
2018
Q2 | – | Sell |
-4
| Closed | – | – | 4154 |
|
2018
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 4188 |
|